Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma(†)

OBJECTIVE: This single-arm, open-label, Phase II study evaluated the efficacy and safety of single-agent bevacizumab, a monoclonal antibody against vascular endothelial growth factor, in Japanese patients with recurrent malignant glioma. METHODS: Patients with histologically confirmed, measurable gl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nagane, Motoo, Nishikawa, Ryo, Narita, Yoshitaka, Kobayashi, Hiroyuki, Takano, Shingo, Shinoura, Nobusada, Aoki, Tomokazu, Sugiyama, Kazuhiko, Kuratsu, Junichi, Muragaki, Yoshihiro, Sawamura, Yutaka, Matsutani, Masao
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3448378/
https://ncbi.nlm.nih.gov/pubmed/22844129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hys121
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados